H. Sindermann

3.3k total citations · 1 hit paper
40 papers, 2.4k citations indexed

About

H. Sindermann is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Epidemiology. According to data from OpenAlex, H. Sindermann has authored 40 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 14 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in H. Sindermann's work include Research on Leishmaniasis Studies (15 papers), Cancer therapeutics and mechanisms (8 papers) and Toxin Mechanisms and Immunotoxins (5 papers). H. Sindermann is often cited by papers focused on Research on Leishmaniasis Studies (15 papers), Cancer therapeutics and mechanisms (8 papers) and Toxin Mechanisms and Immunotoxins (5 papers). H. Sindermann collaborates with scholars based in Germany, Netherlands and India. H. Sindermann's co-authors include T. K. Jha, Shyam Sundar, J. Engel, Klaus Junge, Christina Fischer, A.D.M. Bryceson, Juergen Engel, Jonathan Berman, C.P. Thakur and Jaime Soto and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Biochemistry.

In The Last Decade

H. Sindermann

39 papers receiving 2.3k citations

Hit Papers

Oral Miltefosine for Indian Visceral Leishmaniasis 2002 2026 2010 2018 2002 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Oral Miltefosine for Indian Visceral Leishmaniasis
    2002 568 citations Shyam Sundar, T. K. Jha et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Sindermann Germany 23 1.6k 911 606 398 278 40 2.4k
Derek P. Nolan Ireland 26 1.1k 0.7× 1.8k 2.0× 1.0k 1.7× 261 0.7× 237 0.9× 49 2.8k
Juergen Engel United States 13 710 0.4× 391 0.4× 335 0.6× 281 0.7× 150 0.5× 21 1.3k
Helen P. Price United Kingdom 21 793 0.5× 653 0.7× 738 1.2× 77 0.2× 230 0.8× 60 2.2k
Theresa H.T. Coetzer South Africa 22 415 0.3× 433 0.5× 596 1.0× 113 0.3× 141 0.5× 61 1.6k
Ian Bathurst United States 25 967 0.6× 231 0.3× 820 1.4× 139 0.3× 132 0.5× 65 2.1k
Barbara Clough United Kingdom 25 509 0.3× 475 0.5× 733 1.2× 100 0.3× 569 2.0× 38 1.8k
Karen M. Grant United Kingdom 16 432 0.3× 366 0.4× 529 0.9× 209 0.5× 59 0.2× 31 1.1k
Charles W. Todd United States 25 376 0.2× 432 0.5× 628 1.0× 101 0.3× 269 1.0× 64 1.7k
Sharon Yeoh United Kingdom 15 647 0.4× 159 0.2× 640 1.1× 82 0.2× 169 0.6× 23 1.6k
Nallely Cabrera Mexico 18 426 0.3× 405 0.4× 466 0.8× 120 0.3× 194 0.7× 49 1.1k

Countries citing papers authored by H. Sindermann

Since Specialization
Citations

This map shows the geographic impact of H. Sindermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Sindermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Sindermann more than expected).

Fields of papers citing papers by H. Sindermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Sindermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Sindermann. The network helps show where H. Sindermann may publish in the future.

Co-authorship network of co-authors of H. Sindermann

This figure shows the co-authorship network connecting the top 25 collaborators of H. Sindermann. A scholar is included among the top collaborators of H. Sindermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Sindermann. H. Sindermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hackbarth, H., et al.. (2015). Renal Handling of Albumin: Clearance Studies with Bovine and Rat Serum Albumin in Conscious Rats1. Contributions to nephrology. 19. 225–230.
3.
4.
Unger, Clemens, Wolfgang E. Berdel, Axel‐R. Hanauske, et al.. (2010). First-time-in-man and pharmacokinetic study of weekly oral perifosine in patients with solid tumours. European Journal of Cancer. 46(5). 920–925. 32 indexed citations
5.
Bhattacharya, Sujit, Prabhat Kumar Sinha, Shyam Sundar, et al.. (2007). Phase 4 Trial of Miltefosine for the Treatment of Indian Visceral Leishmaniasis. The Journal of Infectious Diseases. 196(4). 591–598. 170 indexed citations
6.
Soto, Jaime, Julia Toledo, L Valda, et al.. (2007). Treatment of Bolivian Mucosal Leishmaniasis with Miltefosine. Clinical Infectious Diseases. 44(3). 350–356. 98 indexed citations
7.
Vink, Stefan R., Jan H.M. Schellens, Jos H. Beijnen, et al.. (2006). Phase I and pharmacokinetic study of combined treatment with perifosine and radiation in patients with advanced solid tumours. Radiotherapy and Oncology. 80(2). 207–213. 59 indexed citations
8.
Berman, Jonathan, A.D.M. Bryceson, Simon L. Croft, et al.. (2006). Miltefosine: issues to be addressed in the future. Transactions of the Royal Society of Tropical Medicine and Hygiene. 100. S41–S44. 30 indexed citations
9.
Sindermann, H., et al.. (2004). Oral Miltefosine for Leishmaniasis in Immunocompromised Patients: Compassionate Use in 39 Patients with HIV Infection. Clinical Infectious Diseases. 39(10). 1520–1523. 92 indexed citations
10.
Verheij, Marcel, Stefan R. Vink, Jan H.M. Schellens, et al.. (2004). Phase I study of combined treatment with the oral alkyl-lysophospholipid (ALP) Perifosine and radiation in patients with advanced solid tumors. Journal of Clinical Oncology. 22(14_suppl). 3064–3064. 4 indexed citations
11.
Sindermann, H., Simon L. Croft, Kirsten Engel, et al.. (2003). Miltefosine (Impavido): the first oral treatment against leishmaniasis. Medical Microbiology and Immunology. 193(4). 173–180. 62 indexed citations
12.
Sundar, Shyam, T. K. Jha, H. Sindermann, et al.. (2003). Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis. The Pediatric Infectious Disease Journal. 22(5). 434–438. 70 indexed citations
13.
Sundar, Shyam, T. K. Jha, C.P. Thakur, et al.. (2002). Oral Miltefosine for Indian Visceral Leishmaniasis. New England Journal of Medicine. 347(22). 1739–1746. 568 indexed citations breakdown →
14.
Smorenburg, Carolien H., et al.. (2000). Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients. Anti-Cancer Drugs. 11(10). 825–828. 55 indexed citations
15.
Terwogt, Jetske M. Meerum, et al.. (1999). Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer. British Journal of Cancer. 79(7-8). 1158–1161. 50 indexed citations
16.
Sindermann, H., H Junge, & K. Burk. (1994). Miltefosine Solution: Prognostic Factors for the Outcome of Topical Treatment of Skin Meta-static Breast Cancer. Oncology Research and Treatment. 17(1). 21–26. 3 indexed citations
17.
Dummer, Reinhard, et al.. (1993). Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: Results of a phase I/II study. Journal of the American Academy of Dermatology. 29(6). 963–970. 51 indexed citations
18.
Danhauser-Riedl, S., U. Bruntsch, M. Peukert, et al.. (1991). Phase I Study of Weekly Oral Miltefosine (Hexadecyl-Phosphocholine) in Cancer Patients. Oncology Research and Treatment. 14(5). 392–400. 14 indexed citations
19.
Unger, Clemens, M. Peukert, H. Sindermann, et al.. (1990). Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients. Cancer Treatment Reviews. 17(2-3). 243–246. 50 indexed citations
20.
Hackbarth, H., et al.. (1982). The Renal Clearance of Albumin following Intravenous Loading of Homologous Albumin in Conscious Rats. Kidney & Blood Pressure Research. 5(2). 88–94. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Derek P. Nolan Breakdown of academic impact, for papers by Juergen Engel Breakdown of academic impact, for papers by Helen P. Price Breakdown of academic impact, for papers by Theresa H.T. Coetzer Breakdown of academic impact, for papers by Ian Bathurst Breakdown of academic impact, for papers by Barbara Clough Breakdown of academic impact, for papers by Karen M. Grant Breakdown of academic impact, for papers by Charles W. Todd Breakdown of academic impact, for papers by Sharon Yeoh Breakdown of academic impact, for papers by Nallely Cabrera
Rankless by CCL
2026